Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
These maps provide a common framework for discussing the therapeutic development process.
Review a list of all the innovative programs and initiatives that NCATS supports.
Through the NCATS-Eli Lilly externship, CTSA Program Scholar Josephine Taverna, M.D., learns new approaches to drive her research forward.
NCATS offers in-person and online training workshops designed to share best practices and expert advice on assay design, development and implementation.
Read about rare disease patients finding hope in research, how NCATS and Karolinska Institutet scientists are attacking cancer, new online assay guidance modules, and more.
Scientists from NCATS and Sweden’s Karolinska Institutet have developed a potential new approach to fighting cancer by breaking down a defense system used by cancer cells.
NCATS supports rare disease patients and their communities by providing research funding, tools and other resources to help address their unique challenges.
The NIH Common Fund launches a somatic cell genome editing research program
NIH collaboration leverages CTSA Program for research mentoring support
Christopher P. Austin, M.D.
View funded activities under the NCATS Clinical and Translational Science Awards Program. (PDF - 80KB)
Interested in creating biologically, physiologically and pharmacologically relevant assays for early-stage drug discovery? Check out our best-practices Assay Guidance Manual.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …